U.S. drops COVID-19 testing for incoming international air travelers

WASHINGTON, June 10 (Reuters) – The United States late Friday rescinded a 17-month-old requirement that people arriving in the country by air test negative for COVID-19, a move that follows intense lobbying by airlines and the travel industry. Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky issued a four-page order lifting the mandate,… Continue reading U.S. drops COVID-19 testing for incoming international air travelers

U.S. says some Indian officials ignoring or supporting attacks on minorities

NEW DELHI, June 3 (Reuters) – Some officials in India are ignoring or even supporting rising attacks on people and places of worship in the country, a U.S. official said late on Thursday after the release of a report on religious freedom globally in 2021. The report said attacks on members of religious minority communities,… Continue reading U.S. says some Indian officials ignoring or supporting attacks on minorities

U.S. FDA advisers to discuss additional COVID vaccine boosters

April 4 (Reuters) – The U.S. Food and Drug Administration’s staff said on Monday that expert advisers would discuss the timing and populations for use of additional COVID-19 vaccine boosters doses in a meeting later this week. A panel of independent advisers to the agency will also weigh on the role of the FDA in… Continue reading U.S. FDA advisers to discuss additional COVID vaccine boosters

U.S. warns India, others against sharp rise in Russian oil imports -official

NEW DELHI, March 31 (Reuters) – A significant increase in Russian oil imports by India could expose New Delhi to a “great risk” as the United States prepares to step up enforcement of sanctions against Moscow for its invasion of Ukraine, a senior U.S. administration official said. While the current U.S. sanctions against Russia do… Continue reading U.S. warns India, others against sharp rise in Russian oil imports -official

U.S. authorizes second COVID booster for Americans 50 and older

March 29 (Reuters) – U.S. health officials on Tuesday authorized a second COVID-19 booster dose of the two most commonly used COVID-19 vaccines for people age 50 and older, citing data showing waning immunity and the risks posed by Omicron variants of the virus. The U.S. Food and Drug Administration agency said the new boosters… Continue reading U.S. authorizes second COVID booster for Americans 50 and older

Biden says India ‘shaky’ in acting against old Cold War ally Russia

NEW DELHI, March 22 (Reuters) – U.S. President Joe Biden has said only India among the Quad group of countries was “somewhat shaky” in acting against Russia over its invasion of Ukraine, as India tries to balance its ties with Russia and the West. While the other Quad countries – the United States, Japan and… Continue reading Biden says India ‘shaky’ in acting against old Cold War ally Russia

First Omicron case in U.S. adds to global alarm over virus variant

TOKYO/WASHINGTON, Dec 2 (Reuters) – Fears over the impact of the Omicron variant of the coronavirus rose on Thursday after the first case was reported in the United States and the Japanese central bank warned of economic pain as countries respond with tighter containment measures. The first known U.S. case was a fully vaccinated person… Continue reading First Omicron case in U.S. adds to global alarm over virus variant

U.S. senators urge Biden to avoid India sanctions over Russian deal

NEW DELHI, Oct 27 (Reuters) – Two U.S. senators have urged President Joe Biden to waive sanctions against India over its purchase of Russia’s S-400 air defence system, saying such a punitive measure would endanger growing cooperation. India signed a $5.5 billion deal with Russia in 2018 for five of the surface-to-air missile systems for… Continue reading U.S. senators urge Biden to avoid India sanctions over Russian deal

AstraZeneca seeks U.S. authorisation of drug to prevent COVID-19

Oct 5 (Reuters) – AstraZeneca (AZN.L) has requested the U.S. Food and Drug Administration to grant emergency use authorisation for its new treatment to prevent COVID-19, the British drugmaker said on Tuesday. The company has included data from a late-stage trial of over 5,000 participants that showed the drug reduced the risk of people developing… Continue reading AstraZeneca seeks U.S. authorisation of drug to prevent COVID-19

AstraZeneca COVID-19 vaccine 76% effective in new analysis of U.S. trial

(Reuters) – AstraZeneca said its COVID-19 vaccine was 76% effective at preventing symptomatic illness in a new analysis of its major U.S. trial – a tad lower than the level announced earlier this week in a report that was criticised for using outdated information. U.S. health officials had publicly rebuked the drugmaker for not using… Continue reading AstraZeneca COVID-19 vaccine 76% effective in new analysis of U.S. trial